GB1529960A - Treating mammals with 5-methyl-1-phenyl-2-(1h)pyridone - Google Patents

Treating mammals with 5-methyl-1-phenyl-2-(1h)pyridone

Info

Publication number
GB1529960A
GB1529960A GB50479/75A GB5047975A GB1529960A GB 1529960 A GB1529960 A GB 1529960A GB 50479/75 A GB50479/75 A GB 50479/75A GB 5047975 A GB5047975 A GB 5047975A GB 1529960 A GB1529960 A GB 1529960A
Authority
GB
United Kingdom
Prior art keywords
pyridone
phenyl
methyl
administered
alleviating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB50479/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AFFILIATED MED RES
Original Assignee
AFFILIATED MED RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/530,684 external-priority patent/US3974281A/en
Application filed by AFFILIATED MED RES filed Critical AFFILIATED MED RES
Publication of GB1529960A publication Critical patent/GB1529960A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
GB50479/75A 1974-12-09 1975-12-09 Treating mammals with 5-methyl-1-phenyl-2-(1h)pyridone Expired GB1529960A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/530,684 US3974281A (en) 1972-12-18 1974-12-09 5-Methyl-1-phenyl-2-(1H)-pyridone compositions and methods of use

Publications (1)

Publication Number Publication Date
GB1529960A true GB1529960A (en) 1978-10-25

Family

ID=24114565

Family Applications (1)

Application Number Title Priority Date Filing Date
GB50479/75A Expired GB1529960A (en) 1974-12-09 1975-12-09 Treating mammals with 5-methyl-1-phenyl-2-(1h)pyridone

Country Status (5)

Country Link
JP (1) JPS51128437A (da)
AU (1) AU508824B2 (da)
DK (1) DK555875A (da)
GB (1) GB1529960A (da)
ZA (1) ZA757570B (da)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004058256A1 (en) * 2002-12-26 2004-07-15 Kdl, Inc. Pharmaceutical liquid composition containing pyridone derivative
EP2670242A1 (en) * 2011-01-31 2013-12-11 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
WO2014018668A2 (en) 2012-07-24 2014-01-30 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US9770443B2 (en) 2014-01-10 2017-09-26 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02215719A (ja) * 1989-02-15 1990-08-28 Yamauchi Akitomo 線維化病変組織の修復並びに線維化病変の阻止剤
BR9406461A (pt) * 1993-05-07 1996-01-30 Solomon Begelfor Margolin Composições e métodos para a reparação e prevenção de les~es fibróticas
MX2007014114A (es) * 2005-05-10 2008-03-14 Intermune Inc Derivados de piridona para modular el sistema de proteina cinasa activada por estres.
MX2007009796A (es) * 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7605173B2 (en) 2002-12-26 2009-10-20 Kdl, Inc. Pharmaceutical liquid composition containing pyridone derivative
WO2004058256A1 (en) * 2002-12-26 2004-07-15 Kdl, Inc. Pharmaceutical liquid composition containing pyridone derivative
US10092552B2 (en) 2011-01-31 2018-10-09 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
EP2670242A1 (en) * 2011-01-31 2013-12-11 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
JP2014503598A (ja) * 2011-01-31 2014-02-13 ジェノア ファーマシューティカルズ，インク． エアロゾルのピルフェニドンおよびピリドンアナログの化合物、および、その使用
EP2670242A4 (en) * 2011-01-31 2015-02-25 Genoa Pharmaceuticals Inc ANALYZED PYRIDONE AND PIRFENIDONE AEROSOL COMPOUNDS, AND USES THEREOF
AU2012212269B2 (en) * 2011-01-31 2016-05-19 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
EP4059499A1 (en) * 2011-01-31 2022-09-21 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
AU2016213708B2 (en) * 2011-01-31 2018-05-10 Avalyn Pharma Inc. Aerosol pirfenidone and pyridine analog compounds and uses thereof
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
WO2014018668A2 (en) 2012-07-24 2014-01-30 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10028966B2 (en) 2014-01-10 2018-07-24 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US9770443B2 (en) 2014-01-10 2017-09-26 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof

Also Published As

Publication number Publication date
DK555875A (da) 1976-06-10
AU508824B2 (en) 1980-04-03
AU8738375A (en) 1977-06-16
JPS51128437A (en) 1976-11-09
ZA757570B (en) 1977-07-27

Similar Documents

Publication Publication Date Title
Alván et al. Pharmacokinetics of indomethacin
Padilla et al. Mental health service utilization by Mexican Americans.
Ettlinger Suicides in a group of patients who had previously attempted suicide.
Stoeckel et al. Plasma fentanyl concentrations and the occurrence of respiratory depression in volunteers
Scheinman et al. Use of atropine in patients with acute myocardial infarction and sinus bradycardia.
GB1529960A (en) Treating mammals with 5-methyl-1-phenyl-2-(1h)pyridone
Shapiro et al. The experience of introversion: An integration of phenomenological, empirical, and Jungian approaches.
Pollak Integrating sociological and psychoanalytic concepts: an exploration in child psychotherapy.
Katz et al. Penicillin-induced generalized pustular psoriasis
Polak et al. Studies on the effect of systemic administration of sensitizers in guinea-pigs with contact sensitivity to inorganic metal compounds. II. The flare-up of previous test sites of contact sensitivity and the development of a generalized rash
Lehman Further Studies on the Acute Toxicity of Mercurial Diuretics.
GB1334327A (en) Compositions for and method of combating virus infections
Binkley et al. Dermatitis from penicillin: report of two cases
Wexler et al. Toxic reactions to the intravenous injection of mercurial diuretics
GB1311685A (en) Transistors
Cuvo Decreasing repetitive behavior in an institutionalized mentally retarded resident.
Lowe et al. Four years' experience of sulphone treatment of leprosy
Rodionova The effect of dimedrol on the development of Shwartzman's phenomenon
CURRENT et al. The effect of 2, 3-dimercaptopropanol (BAL) on thyroid function
Haden et al. Manifestations of myocardial involvement in acute reactions to penicillin∗
Powell et al. Factors affecting attendance at an alcoholic day hospital.
MD Noradrenaline and external cardiac massage in cardiac arrest.
Robertson Infection in Granulopenia
Shulman A Possible Mode of Action of 2: 4-Diamino-5-phenyl-thiazole Hydrochloride (Daptazole or Amiphenazole)
MORKVENAS Probabilistic methods of the convergence of approximations of integrodifferential equations

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee